Experimental and calculated shift in pKa upon binding of phosphotyrosine peptide to the SH2 domain of p56lck

被引:19
作者
de Mol, NJ [1 ]
Gillies, MB [1 ]
Fischer, MJE [1 ]
机构
[1] Univ Utrecht, Fac Pharm, Utrecht Inst Pharmaceut Sci, Dept Med Chem, NL-3508 TB Utrecht, Netherlands
关键词
D O I
10.1016/S0968-0896(01)00407-2
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The pH dependence of the affinity of a 11-mer phosphotyrosine (pY) peptide (EPQpYEEIPIYL-NH2) for the SH2 domain of the tyrosine kinase p56(lck) was investigated with surface plasmon resonance (SPR). From SPR competition experiments the affinity in solution was obtained. The pH dependence of the affinity in solution can be well described by a proton linkage model with a single pK(a) shift upon binding, from 6.1 to 4.7. This shift is ascribed to the transition from the -2 to the -1 ionisation state of the tyrosine phosphate group. Based on the X-ray structure for the complex with Lck SH2, a pK(a) value of 5.3 for the bound pY peptide was computed, modelling the solvated protein as a system of point charges in a continuum. With the phosphate in the -2 state the binding energy is 1.8 kcal/mol more favourable than for the -1 state, corresponding to a 20-fold higher affinity. A proper charge is relevant in the design of potential therapeutic Lck SH2 ligands with mimics for the metabolically unstable tyrosine phosphate group. (C) 20021 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:1477 / 1482
页数:6
相关论文
共 22 条
  • [1] PREDICTION OF PH-DEPENDENT PROPERTIES OF PROTEINS
    ANTOSIEWICZ, J
    MCCAMMON, JA
    GILSON, MK
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 1994, 238 (03) : 415 - 436
  • [2] Ligands for the tyrosine kinase p56lck SH2 domain:: Discovery of potent dipeptide derivatives with monocharged, nonhydrolyzable phosphate replacements
    Beaulieu, PL
    Cameron, DR
    Ferland, JM
    Gauthier, J
    Ghiro, E
    Gillard, J
    Gorys, V
    Poirier, M
    Rancourt, J
    Wernic, D
    Llinas-Brunet, M
    Betageri, R
    Cardozo, M
    Hickey, ER
    Ingraham, R
    Jakes, S
    Kabcenell, A
    Kirrane, T
    Lukas, S
    Patel, U
    Proudfoot, J
    Sharma, R
    Tong, L
    Moss, N
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (10) : 1757 - 1766
  • [3] Botfield M.C., 1995, ANN REP MED CHEM, V30, P227, DOI [10.1016/S0065-7743(08)60937-9, DOI 10.1016/S0065-7743(08)60937-9]
  • [4] Calorimetric investigation of proton linkage by monitoring both the enthalpy and association constant of binding: Application to the interaction of the Src SH2 domain with a high-affinity tyrosyl phosphopeptide
    Bradshaw, JM
    Waksman, G
    [J]. BIOCHEMISTRY, 1998, 37 (44) : 15400 - 15407
  • [5] Briggs JM, 1999, REV COMP CH, V13, P249, DOI 10.1002/9780470125908.ch5
  • [6] CHARMM - A PROGRAM FOR MACROMOLECULAR ENERGY, MINIMIZATION, AND DYNAMICS CALCULATIONS
    BROOKS, BR
    BRUCCOLERI, RE
    OLAFSON, BD
    STATES, DJ
    SWAMINATHAN, S
    KARPLUS, M
    [J]. JOURNAL OF COMPUTATIONAL CHEMISTRY, 1983, 4 (02) : 187 - 217
  • [7] NONHYDROLYZABLE PHOSPHOTYROSYL MIMETICS FOR THE PREPARATION OF PHOSPHATASE-RESISTANT SH2 DOMAIN INHIBITORS
    BURKE, TR
    SMYTH, MS
    OTAKA, A
    NOMIZU, M
    ROLLER, PP
    WOLF, G
    CASE, R
    SHOELSON, SE
    [J]. BIOCHEMISTRY, 1994, 33 (21) : 6490 - 6494
  • [8] Progress in the development of inhibitors of SH2 domains
    Cody, WL
    Lin, ZW
    Panek, RL
    Rose, DW
    Rubin, JR
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2000, 6 (01) : 59 - 98
  • [9] Kinetic analysis of the mass transport limited interaction between the tyrosine kinase Ick SH2 domain and a phosphorylated peptide studied by a new cuvette-based surface plasmon resonance instrument
    de Mol, NJ
    Plomp, E
    Fischer, MJE
    Ruijtenbeek, R
    [J]. ANALYTICAL BIOCHEMISTRY, 2000, 279 (01) : 61 - 70
  • [10] RECOGNITION OF A HIGH-AFFINITY PHOSPHOTYROSYL PEPTIDE BY THE SRC HOMOLOGY-2 DOMAIN OF P56(LCK)
    ECK, MJ
    SHOELSON, SE
    HARRISON, SC
    [J]. NATURE, 1993, 362 (6415) : 87 - 91